Elise Nassif Haddad, MD

Assistant Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Disclosure information not submitted.

Presentation(s):

• Paper 03 - INTEGRATED ATLAS OF SINGLE CELL TRANSCRIPTOME AND CHROMATIN ACCESSIBILITY IN LEIOMYOSARCOMA

  Thursday, November 14, 2024
  8:30 AM – 10:00 AM PST

• Paper 07 - SPATIAL TRANSCRIPTOMICS REVEALS UNIQUE TRANSCRIPTIONAL AND IMMUNE PROFILES OF PRIMARY UNDIFFERENTIATED PLEOMORPHIC, EPITHELIOID, AND CLEAR CELL SARCOMAS AND PAIRED LYMPH NODE METASTASES

  Thursday, November 14, 2024
  8:30 AM – 10:00 AM PST

• Paper 46 - SINGLE CELL ATLAS OF WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA SUGGESTS UNDERLYING EPIGENETIC PROGRAMS DRIVING TRANSTION BETWEEN WELL- AND DE-DIFFERENTIATED STATES

  Friday, November 15, 2024
  9:00 AM – 10:00 AM PST

• Paper 53 - ADDRESSING THE PRIMARY SITE IN PATIENTS WITH METASTATIC SOFT TISSUE SARCOMA: IS THERE A ROLE FOR A COMBINED MODALITY TREATMENT?

  Friday, November 15, 2024
  11:15 AM – 12:45 PM PST

• Paper 99 - INCIDENCE OF GERMLINE GENETIC MUTATIONS IDENTIFIED ON STANDARD-OF-CARE GENOMIC SEQUENCING FOR ADVANCED SARCOMAS

  Saturday, November 16, 2024
  2:00 PM – 3:00 PM PST